- Topic
- Product safety
- Regulator
- FDA
- Published
- 25 September 2026
- For
- Imports
- Where it applies
- United States
From the notice
The Food and Drug Administration (FDA or the Agency) is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) permanently debarring Naveed Aslam from providing services in any capacity to a person that has an approved or pending drug product application. FDA bases this order on a finding that Dr. Aslam was convicted of a felony under Federal law for conduct that relates to the regulation of a drug product under the FD&C Act. Dr. Aslam was given notice of the proposed debaThe full text is at the source
Olive tells you which of these hit your products.
Olive reads every change like these against your own products, codes and trade lanes, whether you import, export or both, and drafts the update to your compliance program for your approval. Nothing changes without you.
Olivra lists official notices for information only. It is not legal advice, and Olive is not a lawyer or a licensed customs broker. The official text at the source is what counts.
More from FDA
- Safety
Determination That Oxandrin (Oxandrolone) Tablets, 2.5 Milligrams and 10 Milligrams, Were
FDAUnited StatesImports - Safety
Design and Safety Considerations for Clinical Trials Involving Ibogaine Drug Products; Request
FDAUnited StatesImports - Safety
Determination PRALIDOXIME CHLORIDE (Autoinjector) (Pralidoxime Chloride) Solution, 600
FDAUnited StatesImports - Safety
Issuance of Priority Review Voucher; Rare Pediatric Disease Product; FAYUVI (rebisufligene
FDAUnited StatesImports